Alternative Cancer Treatment | Cancer Cure | Cancer Remedies

Although this is an orthodox chemotherapy treatment, it is substantial news, and I decided to speak about it nevertheless because of the high scrutiny under which Avastin (bevacizumab) has been subjected.  This substance already has approval for a variety of cancers, such as colon, brain, kidney, and lung cancers.

Bevacizumab (Avastin) works by blocking angiogenesis (i.e., the growth of new blood vessels that enable tumors to grow).  It is a humanized monoclonal antibody that inhibits vascular endothelial growth factor A (VEGF-A). It was the first angiogenesis inhibitor available in the United States for clinical applications.  It received its first approval for cancer treatment in 2004 when used in combination with standard chemotherapy for metastatic colon cancer and non-small cell lung cancer. continue reading…

Dr Samuel S. Epstein, a world-renowned professor emeritus of Environmental and Occupational Medicine from the University of Illinois School of Public Health, wrote a scathing indictment of the orthodox cancer establishment.  He has written over 250 peer-reviewed journal articles and 20 books on medical topics.  He is one of the world’s leading critics of the cancer establishment with his insightful, highly documented analysis of the cancer industry.

In short, Epstein’s book (entitled NATIONAL CANCER INSTITUTE and AMERICAN CANCER SOCIETY: Criminal Indifference to Cancer Prevention and Conflicts of Interest) states that the National Cancer Institute (NCI) and the American Cancer Society (ACS), as well as the cancer industry in general, are more focused on profits and maintaining the status quo of orthodox cancer treatments.  There has been no organizational focus on cancer prevention. This is one reason why cancer incidence rates have increased at an astronomical rate. continue reading…